Nearly 40% of pregnancy-capable patients with rheumatic disease are unaware of the potential impacts of their medications on ...

medication teratogenicity, and complications such as preeclampsia or fetal growth restriction.” Also read | Epilepsy and seizures: Know myths vs. facts; doctor explains “Women with epilepsy ...

Our results from this study strongly support the use of zebrafish as an alternative in vivo method for screening and assessing the teratogenicity of candidate drugs for regulatory acceptance.